Top Health-care stocks:
Health-care shares were mainly unchanged in pre-market trade Friday.
In health-care stocks news, biotechnology company Heron Therapeutics ( HRTX ) Friday said it has been notified by the U.S. FDA that the agency won’t take action on its new drug application for SUSTOL injection until February 2016 instead of meeting the Prescription Drug User Fee Act goal date of January 17.
Shares in the company were unchanged at $23.22 pre-bell. The company has traded between $7.09 and $42.25 over the past 52 weeks.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.